Search results
17 gru 2020 · This update provides the rationale for the change in gonorrhea treatment recommendations to a higher dose (500 mg) of ceftriaxone and removal of azithromycin from the recommended regimen.
11 lip 2024 · There is currently only one recommended treatment for uncomplicated gonorrhea. Expedited Partner Therapy (EPT) is a partner treatment approach where sex partners of patients who test positive for certain sexually transmitted diseases are provided treatment without previous medical evaluation.
22 lip 2021 · Pages in this Section. Gonococcal Infections Among Adolescents and Adults. Gonococcal Infections Among Neonates. Gonococcal Infections Among Infants and Children. Next. Last Reviewed: July 22, 2021.
29 paź 2020 · Gonorrhoea is a major public health concern globally. Increasing incidence and sporadic ceftriaxone-resistant cases, including treatment failures, are growing concerns. The 2020 European gonorrhoea guideline provides up-to-date evidence-based guidance regarding the diagnosis and treatment of gonorrhoea. The updates and recommendations emphasize ...
13 kwi 2022 · The 2021 CDC STI Treatment Guidelines now recommend 500mg ceftriaxone intramuscularly once for the treatment of uncomplicated gonorrhea at all anatomic sites. If coinfection with chlamydia has not been excluded, cotreatment with doxycycline 100mg twice daily for 7 days should be added.
The 2019 CDC STD Surveillance Report found that the annual cases of STIs in the US continued to increase in 2019, totaling more than an estimated 2.5 million cases of chlamydia, gonorrhea, and syphilis; congenital syphilis increased by 279% between 2015 and 2019. 1 STIs have increased across multiple groups, but disproportionately affect racial ...
Previously, the CDC recommended a single 250-mg intramuscular dose of ceftriaxone and a single 1-g oral dose of azithromycin to treat uncomplicated gonorrhea as well as possible coinfection with Chlamydia trachomatis. However, review by CDC staff and other experts during 2018 and 2019 raised concerns about increasing drug resistance.
